| 000 | 01381 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512131526.0 | ||
| 264 | 0 | _c19671212 | |
| 008 | 196712s 0 0 eng d | ||
| 022 | _a0026-0495 | ||
| 024 | 7 |
_a10.1016/0026-0495(67)90188-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDanowski, T S | |
| 245 | 0 | 0 |
_aDiabetes mellitus and obesity: phenformin hydrochloride as a research tool. _h[electronic resource] |
| 260 |
_bMetabolism: clinical and experimental _cSep 1967 |
||
| 300 |
_a865-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAcidosis _xchemically induced |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aCholesterol _xbiosynthesis |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
| 650 | 0 | 4 |
_aFatty Acids, Nonesterified _xblood |
| 650 | 0 | 4 | _aGlucose Tolerance Test |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 |
_aLactates _xblood |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aObesity |
| 650 | 0 | 4 |
_aOxidoreductases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPhenformin _xtherapeutic use |
| 650 | 0 | 4 |
_aPhospholipids _xblood |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 773 | 0 |
_tMetabolism: clinical and experimental _gvol. 16 _gno. 9 _gp. 865-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0026-0495(67)90188-6 _zAvailable from publisher's website |
| 999 |
_c4863422 _d4863422 |
||